Sencilia

Groningen, Netherlands · Founded 2021 · Privately Held (backing)

Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care. Sencilia is based in Groningen, Netherlands and was founded in 2021. It has raised $860,000.

Last price · $/share
—
Implied valuation
—
Total raised
$860K
Last round
—

Who backs Sencilia?

14 investors
InvestorType
Imec.istartOther
Draper UniversityOther
RUG VenturesOther
Triade InvestmentOther
Future Tech Ventures—
Health ~ Holland—
LifeSciences@Work—
Medlim—
Netherlands Organisation for Scientific Research (Netherlands)—
Samenwerkingsverband Noord-Nederland—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sencilia investors

14 investors are on record for Sencilia, including Imec.istart, Draper University, RUG Ventures and Triade Investment.

Free account
More of Sencilia with a free account
  • ·The complete investor list: 14 names
  • ·Watch Sencilia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Sencilia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View